David A. Ricks
Chairman and CEO at ELI LILLY AND COMPANY
Manager
Deal Bio
Expertise (13)
Key Relationships
Sort
Loxo Oncology
Eli Lilly And Company
£6,281m
55 dealmakers
Dermira
£838m
41 dealmakers
IMMUNOCORE
JDRF
£101m
30 dealmakers
Disarm Therapeutics
£103m
7 dealmakers
Sigilon Therapeutics
BLACKROCK
£65m
8 dealmakers
Merus B.v.
£14m
4 dealmakers
Protomer Technologies
£722m
15 dealmakers
BAQSIMI
Amphastar Pharmaceuticals
£866m
VERSANIS
£1,472m
26 dealmakers
Point Biopharma
£1,152m
40 dealmakers
Crossbow Therapeutics
Mirae Asset Venture Investment
£62m
9 dealmakers
Prism Biolab
£7m
Morphic Holding
£2,496m
11 dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.